Early Diagnosis Training Workshop For Early Career Researchers
Friday, 21 August 2015 13:34
An early diagnosis training workshop for early career researchers on 7th October 2015 in London.
Aim: Improving quality of funding applications
Facilitators: Dr Peter Murchie, Dr Fiona Walter and Dr Katriina Whitaker and Dave Manton (CRUK patient involvement coach)
Deadline: 4th September
To apply, fill out the application form and send to Anna Lawrence-Jones by 5pm on 4 September 2015.
- Download application form [ 794 kb ]
BSG Trainee Member wins a UEGW 2015 Top Abstract Prize
Monday, 27 July 2015 15:44
BSG Trainee Member Edmund Derbyshire has won 10,000 Euro from UEG for his abstract "Colonoscopic perforations in the English NHS Bowel Cancer Screening Programme (NHSBCSP) - beware diagnostic perforations and the sigmoid colon". This is one of five prizes awarded for the top abstracts each year. Further details of this prize are available on the UEG website. The BSG would like to congratulate Dr Derbyshire on his achievement.
Cambridge MRC Cancer Research Unit release 'pill on a string' for diagnosing oesophageal cancer
Wednesday, 22 July 2015 07:21
Julie Solomon, BSG Head of Research and Learning
BSG member Professor Rebecca Fitzgerald and her team have developed a less intrusive but more effective way to sample the cells lining the oesophagus. This method uses the CytoSponge™, a compressed open-fibre sponge that opens up once in the throat and can be retrieved easily using an attached cord. The open texture and size of the sponge increase the probability of finding pre-cancerous tissue that might otherwise have been missed by more conventional endoscopic biopsy techniques. An additional benefit of gathering more tissue has been the ability to track changes in the cells that could indicate a change to cancerous tissue. Detecting these changes early is essential, because oesophageal cancer is very difficult to treat. [Professor Fitzgerald won the UEG Research Prize in 2014 for the project to develop CytoSponge™: "Combination of quantifiable genomic assays with a patient friendly non-endoscopic cell retrieval device called Cytosponge™ for management of patients with Barrett's oesophagus".] The BSG congratulates Professor Fitzgerald on her achievements.
Gastroenterology-led TRIGGER trial of transfusion strategies for GI bleeding published in the Lancet
Wednesday, 15 July 2015 12:38
TRIGGER is a multicentre randomised pilot trial comparing red blood cell transfusion strategies for Acute Upper Gastrointestinal Bleeding (AUGIB). Through the examination of liberal and restrictive policies for transfusion, TRIGGER established that, with further research, the way AUGIB is treated in the UK could change significantly, benefitting patients and producing significant cost savings for the NHS.
This work directly followed on from the British Society of Gastroenterology (BSG)-supported UK national audit of GI bleeding, which was led by Kel Palmer and others. The trial was delivered through a successful collaboration within and between UK gastroenterology centres and other groups. Prof John McLaughlin, the BSG's Research Committee Chairman while the trial was being carried out, said "This fantastic piece of work shows the power of collaborative research. Hopefully the NIHR will support a follow-on study of restrictive transfusion for AUGIB, which has the potential to benefit individual patients and the NHS as a whole."
Page 5 of 7